Estriol

Estriol

SCHEMBL5030180

C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O.C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1ESR2

The experimentally established mechanism targets of Estriol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 known ✓ P03372 6/20 1.00
ESR2 known ✓ Q92731 5/20 1.00
LMNA P02545 3/20 1.00
SHBG P04278 3/20 1.00
CYP2C9 P11712 2/20 1.00
CYP2C19 P33261 2/20 1.00
HIF1A Q16665 2/20 1.00
NR3C1 P04150 2/20 1.00
PGR P06401 2/20 1.00
SERPINA6 P08185 2/20 1.00
AR P10275 2/20 1.00
SLC6A4 P31645 2/20 1.00
SNCA P37840 2/20 1.00
SLC6A3 Q01959 2/20 1.00
PTGS1 P23219 1/20 1.00
OR51E2 Q9H255 1/20 1.00
UGT1A10 Q9HAW8 1/20 1.00
HSD17B10 Q99714 3/20 0.72
TSHR P16473 2/20 0.72
STS P08842 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Estriol SCHEMBL12180048 1.00 ESR1 (1.00) ESR1ESR2LMNASHBGCYP2C9
Estriol SCHEMBL14373308 1.00 ESR1 (1.00) ESR1ESR2LMNASHBGCYP2C9
Estriol SCHEMBL4896486 1.00 ESR1 (1.00) ESR1ESR2LMNASHBGCYP2C9
Estriol SCHEMBL7004654 1.00 ESR1 (1.00) ESR1ESR2LMNASHBGCYP2C9
Estriol SCHEMBL223196 1.00 ESR1 (1.00) ESR1ESR2LMNASHBGCYP2C9
Estriol SCHEMBL13123063 1.00 ESR1 (1.00) ESR1ESR2LMNASHBGCYP2C9
Estriol SCHEMBL23743979 1.00 ESR1 (1.00) ESR1ESR2LMNASHBGCYP2C9
Epiestriol SCHEMBL221084 1.00 ESR1 (1.00) ESR1ESR2LMNASHBGCYP2C9
Estriol SCHEMBL223226 1.00 ESR1 (1.00) ESR1ESR2LMNASHBGCYP2C9
Estriol SCHEMBL8941750 1.00 ESR1 (1.00) ESR1ESR2LMNASHBGCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111398219-B Method for sensing and measuring estradiol by adopting graphene multiple signal amplification SPR (surface plasmon resonance) 军事科学院军事医学研究院环境医学与作业医学研究所 2023-03-03 CN disclosed
CN-113063954-A Estrogen time-resolved fluorescence and color development double-signal test strip and preparation method and application thereof 江南大学 2021-07-02 CN disclosed
CN-111398219-A Method for sensing and measuring estradiol by adopting graphene multiple signal amplification SPR (surface plasmon resonance) 军事科学院军事医学研究院环境医学与作业医学研究所 2020-07-10 CN disclosed
CN-110618225-A Method for constructing database to detect hormone 吉林出入境检验检疫局检验检疫技术中心 2019-12-27 CN disclosed
US-20190214145-A1 Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen KUREK ITZHAK (US) 2019-07-11 US disclosed
WO-2008039360-A9 ULTRASOUND-INDUCED DESTRUCTION OF TRACE-LEVEL ESTROGEN HORMONES IN AQUEOUS SOLUTIONS UNIV VILLANOVA (US) 2008-07-10 WO disclosed
WO-2008039360-A2 ULTRASOUND-INDUCED DESTRUCTION OF TRACE-LEVEL ESTROGEN HORMONES IN AQUEOUS SOLUTIONS VILLANOVA UNIVERSITY (US) 2008-04-03 WO disclosed
EP-1590668-A2 SCREENINIG AND TREATMENT METHODS FOR PREVENTION OF PRETERM DELIVERY ADEZA BIOMEDICAL CORPORATION (US) 2005-11-02 EP disclosed
WO-2004071427-A2 SCREENING AND TREATMENT METHODS FOR PREVENTION OF PRETERM DELIVERY ADEZA BIOMEDICAL CORPORATION (US) 2004-08-26 WO disclosed
US-4454232-A IMMONASSAY, SURFACTANTS BIO-RAD LABORATORIES, INC. (US) 1984-06-12 US disclosed